DE2306071A1 - Verfahren zur gewinnung von orgotein aus roten blutzellen - Google Patents
Verfahren zur gewinnung von orgotein aus roten blutzellenInfo
- Publication number
- DE2306071A1 DE2306071A1 DE2306071A DE2306071A DE2306071A1 DE 2306071 A1 DE2306071 A1 DE 2306071A1 DE 2306071 A DE2306071 A DE 2306071A DE 2306071 A DE2306071 A DE 2306071A DE 2306071 A1 DE2306071 A1 DE 2306071A1
- Authority
- DE
- Germany
- Prior art keywords
- orgotein
- red blood
- blood cells
- hemoglobin
- supernatant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108010070915 orgotein Proteins 0.000 title claims description 93
- 229960004534 orgotein Drugs 0.000 title claims description 93
- TUGDLVFMIQZYPA-UHFFFAOYSA-N tetracopper;tetrazinc Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2] TUGDLVFMIQZYPA-UHFFFAOYSA-N 0.000 title claims description 92
- 238000000034 method Methods 0.000 title claims description 58
- 210000003743 erythrocyte Anatomy 0.000 title claims description 37
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 46
- 102000004169 proteins and genes Human genes 0.000 claims description 39
- 108090000623 proteins and genes Proteins 0.000 claims description 39
- 108010054147 Hemoglobins Proteins 0.000 claims description 29
- 102000001554 Hemoglobins Human genes 0.000 claims description 29
- 238000010438 heat treatment Methods 0.000 claims description 26
- 239000006228 supernatant Substances 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 16
- 239000008280 blood Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000001556 precipitation Methods 0.000 claims description 12
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 10
- 238000004108 freeze drying Methods 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 10
- 239000011874 heated mixture Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000007858 starting material Substances 0.000 claims description 3
- 238000005199 ultracentrifugation Methods 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 7
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 238000000108 ultra-filtration Methods 0.000 description 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000003456 ion exchange resin Substances 0.000 description 5
- 229920003303 ion-exchange polymer Polymers 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002808 molecular sieve Substances 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 239000010414 supernatant solution Substances 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 230000009102 absorption Effects 0.000 description 4
- 210000000601 blood cell Anatomy 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010019160 Pancreatin Proteins 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229940055695 pancreatin Drugs 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 108010063312 Metalloproteins Proteins 0.000 description 2
- 102000010750 Metalloproteins Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006862 enzymatic digestion Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000020004 porter Nutrition 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 229940038773 trisodium citrate Drugs 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 1
- -1 3/4 to 1.5 volume Chemical compound 0.000 description 1
- DGZSVBBLLGZHSF-UHFFFAOYSA-N 4,4-diethylpiperidine Chemical compound CCC1(CC)CCNCC1 DGZSVBBLLGZHSF-UHFFFAOYSA-N 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000043280 Hemoglobin, zeta Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000843058 Homo sapiens Hemoglobin subunit zeta Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 206010057040 Temperature intolerance Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000021336 beef liver Nutrition 0.000 description 1
- 239000003130 blood coagulation factor inhibitor Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 230000008543 heat sensitivity Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27327772A | 1972-07-19 | 1972-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2306071A1 true DE2306071A1 (de) | 1974-02-07 |
Family
ID=23043275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2306071A Withdrawn DE2306071A1 (de) | 1972-07-19 | 1973-02-08 | Verfahren zur gewinnung von orgotein aus roten blutzellen |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS5331206B2 (enExample) |
| AT (1) | AT319472B (enExample) |
| AU (1) | AU468022B2 (enExample) |
| CA (1) | CA1013672A (enExample) |
| CH (1) | CH602115A5 (enExample) |
| CS (1) | CS183633B2 (enExample) |
| DD (1) | DD104981A5 (enExample) |
| DE (1) | DE2306071A1 (enExample) |
| DK (1) | DK134914B (enExample) |
| FI (1) | FI48844C (enExample) |
| FR (1) | FR2193027B1 (enExample) |
| GB (1) | GB1423265A (enExample) |
| HU (1) | HU167432B (enExample) |
| IE (1) | IE38565B1 (enExample) |
| IL (1) | IL40955A (enExample) |
| IN (1) | IN138517B (enExample) |
| IT (1) | IT1043861B (enExample) |
| NL (1) | NL7300614A (enExample) |
| NO (1) | NO140982C (enExample) |
| PH (1) | PH12009A (enExample) |
| PL (1) | PL89367B1 (enExample) |
| RO (1) | RO63388A (enExample) |
| SU (1) | SU578836A3 (enExample) |
| ZA (1) | ZA728583B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5712993A (en) * | 1980-06-23 | 1982-01-22 | Fujirebio Inc | Isolation of superoxide dismutase |
| CN113845525A (zh) * | 2021-10-26 | 2021-12-28 | 尹志宽 | 等电点沉淀血红素提取方法 |
-
1972
- 1972-11-28 IL IL40955A patent/IL40955A/xx unknown
- 1972-11-30 HU HUDA301A patent/HU167432B/hu unknown
- 1972-12-04 AU AU49582/72A patent/AU468022B2/en not_active Expired
- 1972-12-04 ZA ZA728583A patent/ZA728583B/xx unknown
- 1972-12-15 CH CH1833272A patent/CH602115A5/xx not_active IP Right Cessation
- 1972-12-20 JP JP12804372A patent/JPS5331206B2/ja not_active Expired
- 1972-12-28 FI FI723677A patent/FI48844C/fi active
- 1972-12-28 DD DD168020*A patent/DD104981A5/xx unknown
-
1973
- 1973-01-09 AT AT16673A patent/AT319472B/de not_active IP Right Cessation
- 1973-01-10 FR FR7300782A patent/FR2193027B1/fr not_active Expired
- 1973-01-16 NL NL7300614A patent/NL7300614A/xx not_active Application Discontinuation
- 1973-02-08 DE DE2306071A patent/DE2306071A1/de not_active Withdrawn
- 1973-02-27 RO RO7300073995A patent/RO63388A/ro unknown
- 1973-03-15 PH PH14432A patent/PH12009A/en unknown
- 1973-04-17 GB GB1857073A patent/GB1423265A/en not_active Expired
- 1973-04-19 IE IE630/73A patent/IE38565B1/xx unknown
- 1973-04-30 IN IN1004/CAL/1973A patent/IN138517B/en unknown
- 1973-05-22 SU SU7301929363A patent/SU578836A3/ru active
- 1973-07-10 CA CA176,076A patent/CA1013672A/en not_active Expired
- 1973-07-12 PL PL1973164022A patent/PL89367B1/pl unknown
- 1973-07-17 IT IT51505/73A patent/IT1043861B/it active
- 1973-07-17 CS CS7300005130A patent/CS183633B2/cs unknown
- 1973-07-18 DK DK397673AA patent/DK134914B/da unknown
- 1973-07-18 NO NO2935/73A patent/NO140982C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5331206B2 (enExample) | 1978-09-01 |
| IN138517B (enExample) | 1976-02-14 |
| DK134914C (enExample) | 1977-07-25 |
| IL40955A (en) | 1975-11-25 |
| RO63388A (fr) | 1978-06-15 |
| IE38565L (en) | 1974-01-19 |
| JPS4950112A (enExample) | 1974-05-15 |
| IT1043861B (it) | 1980-02-29 |
| AU468022B2 (en) | 1975-12-18 |
| HU167432B (enExample) | 1975-10-28 |
| NO140982C (no) | 1979-12-19 |
| FR2193027A1 (enExample) | 1974-02-15 |
| FI48844C (fi) | 1975-01-10 |
| NO140982B (no) | 1979-09-10 |
| PH12009A (en) | 1978-10-06 |
| CS183633B2 (en) | 1978-07-31 |
| NL7300614A (enExample) | 1974-01-22 |
| CA1013672A (en) | 1977-07-12 |
| AU4958272A (en) | 1974-06-06 |
| IE38565B1 (en) | 1978-04-12 |
| GB1423265A (en) | 1976-02-04 |
| SU578836A3 (ru) | 1977-10-30 |
| PL89367B1 (en) | 1976-11-30 |
| CH602115A5 (enExample) | 1978-07-31 |
| DK134914B (da) | 1977-02-07 |
| FI48844B (enExample) | 1974-09-30 |
| FR2193027B1 (enExample) | 1977-07-22 |
| IL40955A0 (en) | 1973-01-30 |
| DD104981A5 (enExample) | 1974-04-05 |
| AT319472B (de) | 1974-12-27 |
| ZA728583B (en) | 1973-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69011136T2 (de) | Verfahren zur Herstellung einer Protein enthaltenden Zusammensetzung. | |
| DE2440529C3 (de) | Hyaluronidase-Präparat aus menschlicher Plazenta | |
| DE2459291A1 (de) | Verfahren zur gleichzeitigen herstellung von drei therapeutisch verwendbaren produkten aus einem ausgangsmaterial | |
| EP0271885B1 (de) | Arzneimittel enthaltend das Gewebeprotein PP4, Verfahren zur Herstellung von PP4 und zu seiner Pasteurisierung sowie die Verwendung von PP4 | |
| DE2201993A1 (de) | Enzympraeparat und Verfahren zu dessen Herstellung | |
| DE3587391T2 (de) | Verfahren zur Rückgewinnung von gereinigten Wachstumshormonen aus genetisch modifizierten Mikro-organismen. | |
| DE2456589C2 (de) | Verfahren zur Herstellung eines Plasminogen-Aktivators und denselben enthaltendes Mittel | |
| EP0101063A2 (de) | Neues Polypeptid mit Wirkung auf das Immunsystem, Verfahren zu seiner Isolierung und Reinigung, seine Verwendung und dieses enthaltende Mittel | |
| EP0367840B1 (de) | Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie | |
| DE2734150C3 (de) | Verfahren zur Herstellung von Human-Lysozympräparaten | |
| DE3124228C2 (de) | Verfahren zur Isolierung von Superoxid-dismutase aus roten Blutzellen | |
| DE2459915B2 (de) | Aktive Verbindung des Plasminogen-Typs, Verfahren zu ihrer Reinigung und ihre Verwendung | |
| EP0145005A2 (de) | Lungen-Surfactant, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung | |
| EP0065286B1 (de) | Verfahren zum Reinigen bzw. Anreichern von biologisch aktiven Proteinen und hierzu geeignetes Mittel | |
| DE2259405A1 (de) | Verfahren zur isolierung von orgotein aus blutzellen | |
| DE3306944C2 (enExample) | ||
| DE3034045C2 (enExample) | ||
| DE2259404A1 (de) | Verfahren zur gewinnung von orgotein aus tierischem gewebe | |
| CH634854A5 (de) | Verfahren zur herstellung organopeptidhaltiger substanzen mit insulinaehnlicher wirksamkeit aus blut oder blutbestandteilen. | |
| EP0180859B1 (de) | Verfahren zur Reinigung sowie Pasteurisierung von Urokinase | |
| DE1617332B2 (de) | Verfahren zum Isolieren eines wasserlöslichen Protein-Metall-Chelats mit antiphlogistischer Wirkung | |
| US3549610A (en) | Method of collecting protein substances having biological activity with respect to the nervous system comprising extraction of protein from submaxillary glands with ammonium sulfate or sodium sulfate | |
| DE2855698C2 (enExample) | ||
| JPS6160050B2 (enExample) | ||
| AT392003B (de) | Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OD | Request for examination | ||
| 8130 | Withdrawal |